Silenor Tablet
Product Images NDC 42847-103

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Silenor (NDC 42847-103). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Currax Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Silenor 01)

FDA Label Image

Principal Display Panel (3 mg Tablet Bottle Label)

Each tablet of this medication contains 3,39 mg of doxepin hydrochloride. A total of 30 tablets are provided for this package equivalent to 3 mg of doxepin. Please refer to the prescribing information for dosage and use. It is required to provide the medication guide for each patient. This medication needs to be kept away from children and stored in a controlled room temperature between 20-25°C or 68°-77°F. Dispense in a tightly closed container. This medication is distributed by Currax™ Pharmaceuticals LLC located in Morristown, NJ 07860. The NDC code is 42847-103-30.*

FDA Label Image

Principal Display Panel (6 mg Tablet Bottle Label)

Silenor is a medication available in 30 tablet form that contains 6.78 mg doxepin hydrochloride, which is equivalent to 6 mg of doxepin. It is recommended to refer to the accompanying Prescribing Information for dosage and usage instructions. A Medication Guide should be given to each patient, and it should be kept out of reach of children. It needs to be stored in a tight, light-resistant container at a controlled room temperature of 20°-25°C (68°-77°F). Currax™ Pharmaceuticals LLC of Morristown, NJ 07960, distribute the medication. SIL-LC084.00 Rev. 05/19.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.